PROM1 and osteosarcoma: PEGylated poly(lactic-co-glycolic acid) carriers containing salinomycin (SAL-NP) and CD133 aptamers (Ap-SAL-NP) efficiently stopped the progression of CD133+ osteosarcoma cancer stem cells (384).